Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anticancer agent 260

Anticanceragent 260 is an orally bioavailable small molecule demonstrating in vitro antiproliferative activity against HCT-116, MIA-PaCa2, and MDA-MB231 cancer cell lines. It also exhibits in vivo relevant properties including analgesic and anti-inflammatory effects, alongside documented induction of ulcer formation and lipid peroxidation in research models.

Product Specifications

CAS Number

345994-70-9

Field of Research

Immunology & Inflammation, Metabolism Research, Signal Transduction

Smiles

N=1N=C (OC1C=2C=CN=CC2) C=3C=CC=CC3C

Molecular Formula

C14H11N3O

Molecular Weight

237.26

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

TBCD
CSB-CL883599HU1 10 μg Plasmid + 200 μL Glycerol

TBCD

Sign In for Pricing
View Details
Human/Mouse PBEF/Visfatin Alexa Fluor 750 Antibody
IC4044S-100UG 100 µg

Human/Mouse PBEF/Visfatin Alexa Fluor 750 Antibody

Sign In for Pricing
View Details
TPMT Antibody
orb1337908 100 µg

TPMT Antibody

Sign In for Pricing
View Details
Il2 3'UTR GFP Stable Cell Line
TU256230 1.0 mL

Il2 3'UTR GFP Stable Cell Line

Sign In for Pricing
View Details
LUC7L (LUC7L1, Putative RNA-binding Protein Luc7-like 1, Putative SR Protein LUC7B1, SR+89, FLJ10231) (AP)
MBS6132159-01 0.1 mL

LUC7L (LUC7L1, Putative RNA-binding Protein Luc7-like 1, Putative SR Protein LUC7B1, SR+89, FLJ10231) (AP)

Sign In for Pricing
View Details
LUC7L (LUC7L1, Putative RNA-binding Protein Luc7-like 1, Putative SR Protein LUC7B1, SR+89, FLJ10231) (AP)
MBS6132159-02 5x 0.1 mL

LUC7L (LUC7L1, Putative RNA-binding Protein Luc7-like 1, Putative SR Protein LUC7B1, SR+89, FLJ10231) (AP)

Sign In for Pricing
View Details